Osaka, Japan
Osaka, Japan
NCT Number: NCT00657579
To investigate the dose-response relationship of DE-104 ophthalmic solution in lowering intraocular pressure (IOP) in subjects with Primary Open-Angle Glaucoma or Ocular Hypertension
Looking for future studies?
Notify Me20 year–74 year
All sexes
Interventional
Phase 2
Osaka, Japan
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Santen Pharmaceutical Co., Ltd.
Industry
A Randomized, Double-Masked, Parallel-Group, Dose-Response Trial of DE-104 Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03891446
Eye Diseases, Glaucoma
Dothan, Alabama, United States
View Trial DetailsNCT03850782
Eye Diseases, Glaucoma
Sun City, Arizona, United States
View Trial DetailsNCT04647214
Eye Diseases, Glaucoma
Culver City, California, United States
View Trial DetailsNCT04910100
Eye Diseases, Glaucoma
Newport Beach, California, United States
View Trial Details